Subcutaneous vs. Intramuscular Testosterone Injections: Which Is Better, and What Actually Changes?

Affiliate disclosure: TRT Provider Guide has commercial relationships with Male Excel and Taurus Meds and may earn a commission from some links on this page. That doesn't change what we report. Read our affiliate disclosure.

Both work. Subcutaneous (SubQ) testosterone injections can produce testosterone exposure comparable with intramuscular (IM) shots in the small studies available, and some studies report less injection pain with SubQ. But SubQ is not proven safer. The real differences are the exact product, FDA labeling, injection experience, schedule, and cost.

That's the short answer to subcutaneous vs intramuscular testosterone injections. Three things can change it for you:

• Your exact product. Only one testosterone injection, Xyosted, is FDA-approved for use under the skin. Standard testosterone cypionate vials are labeled "for intramuscular use only," so using them SubQ is an off-label choice your prescriber makes.
• How often you'll inject. Frequency depends on the product and plan, not the route alone. Xyosted is weekly, while some online SubQ programs are daily. A daily plan is about 365 injections a year; a weekly plan is 52.
• What you're worried about. Fertility, blood pressure and red blood cell counts are affected by testosterone itself. Changing the route doesn't make those risks go away.

One more thing before you choose. The study behind the popular claim that SubQ gives you "41% lower hematocrit" didn't compare the same drug two ways. And that 41% isn't a percentage drop at all. We pulled the authors' own numbers. They're below.

Neither route should be your first decision if: low testosterone hasn't been confirmed with symptoms or signs plus consistently low testosterone on appropriate repeat early-morning testing, you're trying to conceive now or soon, or your clinician has already flagged an elevated hematocrit. Those come first.

TRT Provider Guide is the independent decision resource for testosterone replacement therapy — helping U.S. adults understand how low testosterone is evaluated, compare online and local care models and providers, and choose the next step that fits their health needs, fertility plans, budget, state, and care preferences, with every material claim verified and dated.

Educational information, not medical advice. Don't change your product, dose, schedule or injection route without your prescriber. Chest pain, sudden shortness of breath, or a painful, swollen leg needs urgent or emergency care.

---

Subcutaneous vs intramuscular testosterone injections: the quick comparison

SubQ puts testosterone into the tissue under the skin. IM puts it into muscle. Both can produce therapeutic testosterone levels; the practical differences depend on the exact product, FDA labeling, injection experience, schedule, and cost.

Sources: FDA product labels and the studies linked throughout this page. Table compiled by TRT Provider Guide, September 2026.

What we actually verified

Checked September 20, 2026: current FDA/DailyMed labeling for Xyosted, Depo-Testosterone, testosterone enanthate, Azmiro and Aveed; the FDA's 2025 class-wide testosterone-label change and the additional label changes requested in June 2026; the key SubQ-vs-IM studies and 2022 reviews; AUA and Endocrine Society guidance; the current federal telemedicine extension; current Male Excel injection, pricing and service-area pages; current Taurus Meds offer pages; and current public cash-coupon pricing where quoted below.

Verified: the labeled route for each named FDA-approved injectable product; Xyosted's SubQ approval and July 2025 boxed-warning change; each study's design, population and reported outcomes; the Choi poster's raw hematocrit/estradiol values and regression coefficients; guideline statements cited on this page; and the federal telemedicine extension through December 31, 2026.

Provider-stated, not independently confirmed: Male Excel's daily SubQ program details and compounded/pharmacy-dispensed description; Taurus Meds' weekly-IM wording and advertised $49 start plus $149-per-month offer.

Not established by current evidence: that SubQ is safer overall; that the SubQ route by itself lowers hematocrit or estradiol; that SubQ hurts less for everyone; or that daily injections are clinically better than weekly injections.

Could not independently confirm: the exact vial and dispensing pharmacy any one patient receives before enrollment; Male Excel's shipping amount; Taurus Meds' current state-by-state availability; or an active external affiliate destination in the site registry during this audit. For that reason, commercial CTAs on this page route to TRT Provider Guide's own current provider breakdowns instead of directly to an offer.

We did not enroll, inject anything or inspect a dispensed vial. This is a public-source comparison, not a hands-on review. Our method: How We Review TRT Providers.

---

Is subcutaneous testosterone as effective as intramuscular?

For blood levels, the small studies available say SubQ can be comparable with IM. In a crossover study, people who switched from IM to SubQ on the same drug kept comparable testosterone exposure, and a 2022 Endocrine Society journal review concluded that similar SubQ and IM doses can produce comparable levels. The SubQ evidence base is smaller and shorter than IM's long track record.

Here's what the direct data shows.

In a 2018 crossover study, 14 people already on weekly IM testosterone cypionate or enanthate injected IM for 3 weeks, then SubQ for 8 weeks. Testosterone exposure per milligram was about the same: 1.7 on SubQ versus 1.9 on IM, a difference too small to call real. They also reported less anxiety before the shot, less pain during it, and less pain after.

The only FDA-approved SubQ product has its own numbers. In Xyosted's 52-week study of 150 men with low testosterone, 90% had an average testosterone level in the normal range at week 12, and nobody's peak went above 1,500 ng/dL.

And the big-picture view: a 2022 review in the Endocrine Society's journal found that the available evidence, while limited, shows SubQ testosterone at similar doses produces comparable levels and is easier to self-inject.

The honest limits. These studies are small. Several of the switch studies were in transgender men, not men treated for low testosterone, so the populations are not interchangeable. No large, long, randomized trial has compared SubQ with IM testosterone in men treated for testosterone deficiency.

Does testosterone get "stuck" in belly fat?

No good evidence says it does. In a study of 63 patients on weekly SubQ injections, the dose needed to reach target levels didn't depend on body mass index.

Here's the part that surprises people. Imaging studies cited in that 2022 review estimated that 12% to 85% of shots meant for muscle in men actually landed in fat. So a lot of "IM" injections were already SubQ. The review's authors suggest that may be why IM shots hurt less in heavier men.

Why absorption is a little different

Your muscle's blood and lymph flow speed up when you move. The fat layer's flow stays steadier. That's why the review's authors expect SubQ absorption to swing less with exercise.

In practice, the curve can look different even when the total is similar. Xyosted's SubQ shot peaked about 12 hours after the dose, on average. In a study of a large 4 mL testosterone undecanoate shot, the SubQ version peaked later than IM (8.0 days versus 3.3), but the peak height and the overall levels didn't differ.

Our read: if the question is "can SubQ produce therapeutic testosterone levels," the evidence says yes. The harder questions are the ones below.

---

SubQ or IM: which one fits you?

SubQ may be worth asking about if needle anxiety or deep-muscle injections are the barrier. IM may fit if you want to use a standard vial by its labeled route or your current IM plan works well. If low testosterone is not confirmed or you're trying to have a child, sort that out before choosing either route.

The right TRT provider is not the same for every person — it depends on whether low testosterone has been properly evaluated, your symptoms and health history, your fertility plans, your state, your insurance or cash-pay preference, your treatment-format preference, your budget, and whether online or in-person care is the better starting point. Some situations belong with primary care, urology, endocrinology, reproductive urology, or urgent or emergency care when the symptoms warrant it. Because a general answer cannot resolve those for you, use TRT Provider Guide's Find My TRT Path tool to map your situation to the right care route and the questions to ask before you pay. The tool is educational and non-diagnostic. It doesn't confirm low testosterone or guarantee a prescription.

Find yourself below.

"The needle is the problem."

Then SubQ is a route to ask about. Small studies and a 2022 review generally report less injection discomfort and easier self-administration with SubQ, though not everyone prefers it. If you're going through your own doctor with insurance, ask which SubQ options are appropriate for your exact prescription. If you want an online program built around SubQ, keep reading this section.

"I want the fewest shots."

Then look at weekly IM, or at Xyosted, which is SubQ but once a week. Both are about 52 injections a year. Daily SubQ plans are about 365.

"I want FDA-approved products and my insurance."

Then start with your own primary care doctor, urologist or endocrinologist. Ask about generic testosterone cypionate or enanthate used as labeled, or about Xyosted. Most online TRT programs are cash-pay and many use compounded testosterone, which isn't FDA-approved. Our guide to TRT providers that take insurance is the better next page for you.

"My clinician says my hematocrit is high."

Don't switch routes on your own. A route change might help, but it isn't proven (see the next section). Your prescriber may want to check for sleep apnea, change the dose or schedule, or pause treatment first. Keep this conversation with the clinician who treats you.

"I'm not sure yet."

That's a completely normal place to be. Find My TRT Path helps you map your situation and the questions to ask before you pay anyone.

---

If the needle is what's stood between you and treatment, here's one program built around daily SubQ injections.

Male Excel's injection plan is a daily SubQ shot of testosterone cypionate with an insulin-type syringe. It starts with a $99 at-home hormone test and an online consult.

Here's the tradeoff, straight. Male Excel's current public injection page describes once-daily SubQ testosterone cypionate, so that is about 365 injections a year. If fewer injections matter most to you, a weekly plan or weekly Xyosted prescription may fit better. Male Excel says it uses short, thin insulin-type syringes and home self-injection; those are provider-stated program features, not proof that daily dosing is clinically better than weekly dosing.

One more fit check: Male Excel's current site says its U.S. treatments are compounded and pharmacy-dispensed, and its FAQ lists 11 states where its medical providers do not prescribe hormone treatment. If you want only an FDA-approved finished drug product or live in Alabama, Alaska, Arkansas, Connecticut, Hawaii, Idaho, Louisiana, Minnesota, Mississippi, New Hampshire or Rhode Island, this program does not match that preference or current service area.

Does that sound like your situation? Read our current Male Excel testosterone injections breakdown →

Treatment requires a clinician's evaluation and is never guaranteed. We are routing you to our verified breakdown rather than a direct offer because commercial destinations and pricing can change.

---

Is subcutaneous testosterone FDA approved?

Some of it is. Xyosted, a weekly testosterone enanthate autoinjector, is FDA-approved for SubQ use in the belly. Depo-Testosterone and generic cypionate vials are labeled for intramuscular use only, so injecting them under the skin is off-label. Compounded testosterone isn't FDA-approved at all, so it has no FDA-labeled route.

We pulled the labels for every named injectable testosterone product in the current FDA index. Here's what each one says.

Sources: FDA and DailyMed labels linked above; TRT Provider Guide's FDA-approved testosterone products dataset (verified September 2, 2026); AUA guideline, Statement 28.

What "off-label" means for you

Off-label means an FDA-approved drug is being used in a way its label does not describe. Here, that difference is the route. FDA says clinicians generally may prescribe an approved drug for an unapproved use when they judge it medically appropriate, but FDA has not approved that unapproved route for the product. That is not the same as saying the product itself is "approved for SubQ."

Here's the line to remember: an FDA-approved SubQ testosterone product doesn't change the labeled route of a different testosterone product. Xyosted being approved for SubQ doesn't make a Depo-Testosterone vial approved for SubQ.

If your prescriber wants you to use a vial SubQ, ask why that route is being chosen and have the route and schedule documented clearly in your treatment instructions.

What's actually in your vial: FDA-approved vs compounded

FDA-approved means the FDA reviewed that finished product for safety, effectiveness and quality before it went on sale. Compounded means a pharmacy made a preparation for a patient. The FDA says compounded drugs aren't FDA-approved and aren't reviewed that way before they're sold. A compounded drug isn't a "generic," isn't "the same," and isn't safer or more natural.

The carrier oil and finished formulation also differ by product. Depo-Testosterone uses cottonseed oil, while Xyosted uses sesame oil. Do not assume two products are interchangeable simply because both contain testosterone.

The American Urological Association's guideline says clinicians should prescribe commercially made testosterone rather than compounded testosterone when possible. That's a conditional recommendation, based on limited evidence. It still tells you which question to ask first.

Ask these three before you pay anyone:

1. Is my testosterone an FDA-approved product or a compounded preparation?
2. What oil is it in, and which pharmacy fills it?
3. Is that pharmacy licensed in my state?

Labels are changing right now

In February 2025, the FDA required class-wide labeling changes: cardiovascular boxed-warning language was removed after review of TRAVERSE data, while blood-pressure warnings were added. Xyosted's own blood-pressure boxed warning was removed in July 2025, although a blood-pressure warning remains. In June 2026, HHS and the FDA requested additional testosterone-label changes involving age-related low testosterone and prostate wording. A request is not the same as a completed label revision, so check the current label for your exact product.

---

Does SubQ testosterone lower hematocrit and estrogen?

Maybe, but the SubQ route itself has not been proven to lower hematocrit or estradiol. In the most-cited study, hematocrit rose about 1.5 points on the Xyosted SubQ autoinjector versus 3.2 points on IM cypionate vials over 12 weeks, but the groups used different products and were not randomized. Xyosted's own label shows hematocrit still rose about 5.4 points on average over a year, so monitoring remains necessary.

Two terms first. Hematocrit is the share of your blood made up of red blood cells. Testosterone raises it, and too high can thicken the blood. Estradiol is the main form of estrogen, which men need in the right amount.

The study everyone cites, decoded

Almost every page that says "SubQ lowers hematocrit and estrogen" points to one study: Choi and colleagues, The Journal of Urology, 2022. Here's what it actually compared: weekly IM testosterone cypionate from vials versus weekly Xyosted, a SubQ testosterone enanthate autoinjector. Same weekly amount. Different ester, different product, different device. It looked back at records over 12 weeks.

Here are the averages from the authors' own conference poster:

Source: Choi EJ, et al., authors' poster hosted by UC Irvine Urology; published version J Urol. 2022;207(3):677–683. The published abstract reports nearly identical testosterone figures.

So there was a difference. Hematocrit rose about half as much in the Xyosted group. That's a real finding, and it's why the claim spread.

Now, about "41% lower." The poster's summary says the SubQ group had "41% and 26.5% lower" hematocrit and estradiol. The regression tables right beside it show where those numbers come from: they're standardized coefficients (−0.41 and −0.265). That's a statistics measure of how strongly two things are linked. It is not a 41% drop in your hematocrit. A 41% lower hematocrit would mean about 28% instead of 48%, which isn't what anyone saw. In real units, after adjusting for other factors, the Xyosted group's hematocrit was about 3.3 points lower and estradiol about 10 pg/mL lower.

Four reasons this study can't prove the SubQ route itself lowers hematocrit:

1. Two different drugs. Cypionate vials versus an enanthate autoinjector. The result applies to Xyosted, not to every SubQ shot from a vial.
2. Not randomized. Men weren't assigned by chance. The Xyosted group was younger and started with lower testosterone and lower estradiol.
3. Short. Twelve weeks.
4. The numbers shift between versions. The journal abstract reports 234 men; the poster's methods say 263 and its table lists 302. Small inconsistencies like this are common in early reports, but they're a reason for caution.

What the SubQ product's own label shows

Xyosted's FDA label is the best long-term data we have for SubQ testosterone. Over a year, average hematocrit rose about 5.4 points. About 4.2% of 283 men reached a hematocrit of 55% or higher. A rise in hematocrit was the most common side effect in the one-year study, reported in 14% of men. The label tells doctors to check hematocrit about every three months.

That's not a knock on SubQ. It's a reminder that SubQ testosterone is still testosterone.

What the biggest hematocrit analysis shows

A 2022 network meta-analysis pooled 29 placebo-controlled trials with 3,393 men. IM testosterone cypionate or enanthate raised hematocrit about 4 points compared with placebo. Every formulation raised it. And here's the gap: none of the 29 trials tested SubQ injections. There's no randomized trial showing SubQ shots raise hematocrit less.

What about estrogen?

The evidence conflicts. The Choi study found a smaller estradiol rise with Xyosted. But the 2022 Endocrine Society journal review found that in the few studies measuring it, estradiol rose about the same way regardless of route. Don't add an estrogen-blocking drug because of a route claim. That's your prescriber's call, based on your labs and symptoms.

If your hematocrit is already high

This is a clinical problem, not a DIY fix. The Endocrine Society's guideline calls for evaluating a baseline hematocrit above 48% (or above 50% at high altitude) before starting testosterone. During treatment, it treats a hematocrit above 54% as a reason to stop until it comes down, check for causes like sleep apnea, and restart at a lower dose. Xyosted's label says to stop the drug if hematocrit becomes elevated, until it falls to an acceptable level.

Asking "would a different route or schedule help me?" is a fair question for your prescriber. Switching on your own isn't.

---

What do SubQ vs IM testosterone studies actually compare?

Most compare more than the route. Before trusting any SubQ vs IM claim, check four things: the drug, the device, the route and the schedule. Only a few small studies changed the route alone, and none was a large, long, randomized trial in men treated for low testosterone.

The four-part check. Ask one question about any SubQ vs IM claim: did the study change only the route, or did it also change the drug, the device and the schedule? A weekly enanthate autoinjector, a cypionate vial used IM, and a daily SubQ cypionate plan are three different treatments. A result from one doesn't automatically carry to the others.

Here's every key study we used, with what it can and can't tell you.

Our read: the evidence supports SubQ as a real, reasonable option. It doesn't support calling SubQ "safer," "better" or "the new standard." Anyone who says otherwise is skipping the four-part check.

---

Does SubQ hurt less than IM?

Often, in the small studies of standard-volume cypionate or enanthate injections. People who switched from IM to SubQ reported less anxiety and less pain, and SubQ avoids the specific sciatic-nerve risk of a deep gluteal IM injection. But it isn't one-way: with a large 4 mL undecanoate shot, SubQ hurt more 24 hours later, and 11 of 20 participants preferred IM.

In the Wilson switch study, people reported less pain during and after SubQ injections. Patient-preference studies reviewed in the 2022 Endocrine Society journal review generally favored SubQ, and the review notes that SubQ avoids the small risk of sciatic-nerve injury associated with gluteal IM injections. That does not mean every person or every formulation will hurt less SubQ.

Volume changes things. The Turner study used a large 4 mL shot of testosterone undecanoate. Pain was worse 24 hours after the SubQ version, not right away, and both routes were rated equally acceptable. That's a big-volume shot, not what most people inject at home, but it's a good reminder that "SubQ always hurts less" isn't true.

What goes wrong with each:

• SubQ: small lumps, bruising, bleeding, redness or hardness at the site. In Xyosted's trials, 12.7% of 283 men had an injection-site reaction, and none stopped treatment because of it.
• IM: muscle soreness, and rarely, injury to a nerve near the injection site.

What we won't publish: needle gauges, angles or step-by-step technique. Your prescriber's team should train you and, ideally, watch your first injection. Written steps from a website can't check your technique, and they can't see your body.

---

How often do you inject with SubQ vs IM?

It depends on the product and the plan, not the route alone. Xyosted is labeled for once a week, and its instructions say not to use it every day; Depo-Testosterone is labeled for every 2 to 4 weeks. Some online programs use daily SubQ shots, which means about 365 injections a year versus 52 on a weekly plan.

This is where a lot of SubQ vs IM debates go sideways. Some SubQ programs choose smaller, more frequent dosing, but frequency is a separate variable from route. Changing how often a dose is given can change peak-and-trough patterns regardless of whether the injection is SubQ or IM. So when someone says "SubQ made my levels steadier," the route may not be the only thing that changed.

Your year, in needles:

Frequencies describe labels and provider-stated programs, not a recommendation. Your prescriber sets your schedule.

Neither daily nor weekly has been proven better in a head-to-head study. The daily vs weekly decision is its own conversation. We compare the programs that offer daily shots in our guide to TRT providers with daily injections.

What we won't publish: doses or conversions between schedules. How much you inject, and how often, depends on your labs and your prescriber's judgment.

---

Would you rather do 52 shots a year than about 365?

Taurus Meds' current offer page describes testosterone cypionate as weekly intramuscular injections. It advertises a $49 blood test and consultation, then $149 a month if approved, and says there are no membership or hidden fees. The page also repeats the same "weekly intramuscular injections" sentence under products that are not injections, so treat the route wording as provider-stated and confirm the actual prescribed product and schedule before paying.

If that schedule is closer to what you're looking for, compare Male Excel and Taurus Meds on our current breakdown →

Treatment requires clinician evaluation. Provider approval and a prescription are never guaranteed.

---

How much do SubQ and IM testosterone cost?

Cost depends more on the product and care model than on SubQ versus IM. Generic testosterone cypionate is usually the low-cost medicine path, while Xyosted can be expensive without insurance. Online programs bundle or separate testing, clinician care, medication, supplies and shipping in different ways, so a teaser monthly price is not a complete comparison.

Prices checked September 20, 2026. Coupon prices can change at any time. Provider totals are arithmetic from current published prices, not quotes or guarantees.

Three things the table tells you:

1. The cheapest medicine and the cheapest care program are different things. A generic vial can be inexpensive, but total care also includes clinician visits, labs, supplies and sometimes shipping.
2. Xyosted's on-label SubQ convenience can carry a high cash price. Insurance can change that completely, so check your actual formulary and prior-authorization rules.
3. Do not force a first-year total when a provider's own pages conflict. Male Excel currently publishes enough information to show its basic components, but not consistently enough across current pages for us to publish one definitive 12-month number without guessing.

If Male Excel's daily SubQ plan is still your front-runner, read our current Male Excel injections breakdown → before you follow any commercial link. That page should be re-verified whenever Male Excel changes its pricing.

---

Which is safer, SubQ or IM testosterone?

Neither route has been proven safer overall. Important risks such as higher hematocrit, higher blood pressure, suppression of sperm production and product-specific warnings come from testosterone therapy and the exact product, not from a simple "fat versus muscle" rule. SubQ avoids deep-muscle injection problems, while SubQ products can cause local skin-site reactions.

Sources: Xyosted label; FDA class-wide labeling change; Nackeeran 2022; Figueiredo 2022; Aveed label.

What monitoring looks like on either route. The AUA guideline calls for baseline hemoglobin/hematocrit assessment, an initial follow-up testosterone measurement after an appropriate interval, and testosterone checks every 6 to 12 months once therapy is established. Xyosted's label says to check hematocrit about every three months and periodically monitor blood pressure. For the full testing picture, see our TRT blood test guide.

Get urgent care right away for: chest pain, sudden shortness of breath, or a leg that's painful, swollen, warm or red. These can be signs of a blood clot. Don't wait on an online message.

---

Does SubQ or IM testosterone affect fertility differently?

There is no evidence that choosing SubQ instead of IM removes testosterone's fertility effect. Exogenous testosterone can suppress sperm production; Xyosted's current label says reduced fertility occurs in some men taking testosterone replacement therapy and that the effect may be irreversible. The AUA says exogenous testosterone should not be prescribed to men currently trying to conceive.

Here's why route is not the protection people sometimes hope it is. Testosterone from outside the body suppresses the hypothalamic-pituitary-testicular signals that support sperm production. Changing whether the medicine is deposited under the skin or in muscle does not turn off that feedback effect.

We won't tell you that testosterone will make you infertile. We won't promise it won't, or that fertility will return on a set timeline. This conversation belongs before your first prescription, with a urologist, reproductive urologist or another fertility-aware clinician. Some non-testosterone treatments exist for selected men who want to maintain fertility, but they aren't TRT and they aren't interchangeable with it. The AUA notes that hCG is FDA-approved for use in males in this context, while several other commonly discussed alternatives are used off-label. Our TRT and fertility guide explains that separate decision.

---

Trying to conceive, set on using insurance, or want only FDA-approved products? Any of those changes the right first step more than the SubQ vs IM question does. Find My TRT Path maps your situation to a care route, whether that's a urologist, your own doctor with insurance, or an online program, plus the questions to ask before you pay.

Map my care route with Find My TRT Path →

---

Can you switch from IM to SubQ testosterone?

Yes, but only with your prescriber. Switch studies kept levels steady, yet your lab timing, supplies and sometimes your dose or schedule can change, and a vial may move from on-label to off-label use. Your prescriber should set the new plan and recheck your labs afterward.

Switching on your own causes three problems. Your prescription and pharmacy label won't match what you're doing. Your next lab results can be misread. And the volume or schedule may need to change too, which is your prescriber's decision.

Your lab timing can change. When you draw blood matters, and it depends on the product and schedule. The Endocrine Society's guideline describes checking levels midway between injections for cypionate or enanthate shots. Xyosted's label measures a "trough," the low point right before the next weekly dose, 6 weeks after starting or changing the dose. If nobody tells you when to draw your blood on a new plan, ask.

Bring this to your prescriber:

• Your recent labs, including testosterone and hematocrit
• A plain description of how you feel across your injection week, day by day
• The specific reason you want to switch: pain, needle anxiety, a hematocrit concern, or something else
• A question: "If we switch, when will you recheck my labs, and what would make you switch me back?"

If your current online clinic only offers one route, ask whether they'll prescribe the other. If they won't, the cleaner move may be a provider built around the route you want. See the fit section above.

---

Decode your own injection plan

Look at the box or vial you were given. The product name, the type of testosterone and the printed route tell you whether your plan matches the label, and which questions to ask. This table does the matching for you.

Your 8 questions about injection route

Screenshot this list or copy it into your notes before your consult.

1. Which route do you recommend for me, and why?
2. Is my testosterone FDA-approved or compounded, and what oil is it in?
3. If you want me to use a vial SubQ, will you write that route and schedule on my prescription?
4. Who will train me, and can someone watch my first injection?
5. When will you recheck my testosterone and hematocrit after I start or switch?
6. What hematocrit or blood-pressure result would make you change my plan?
7. What will I pay over the first 12 months, including membership, medication, labs, supplies and shipping?
8. If I'm trying to have children in the next year or two, should I see a urologist first?

---

Claims you'll see online vs what the source says

A lot of SubQ vs IM advice repeats the same few errors. Here's each popular claim next to what the FDA label or the original study actually says, so you can check it yourself.

---

How we researched this page

We read the FDA labels, the original studies and the guidelines ourselves, checked prices on the dates shown, and kept what we verified separate from what providers say about themselves. We don't give medical advice, and no provider paid to be included.

Specifically, we pulled the current labels for every named injectable testosterone product in the FDA index and compared each one's labeled route. We read the most-cited SubQ vs IM study down to the authors' own data tables, and set it beside four other comparison studies and a 2022 review. We checked coupon prices for Xyosted and generic cypionate, and the published prices of two online programs, then did the 12-month arithmetic ourselves.

Provider facts on this page are what each company publishes, cross-checked with our September 2026 provider research. We didn't enroll in either program. We follow How We Review TRT Providers and our editorial standards. If something here is wrong or has changed, tell us and we'll date the correction.

Related reading: Testosterone half-life by form, route and ester · Testosterone injections vs gel · Online vs local TRT care · TRT cost guide

---

Frequently asked questions

Is subcutaneous testosterone as effective as intramuscular?

For blood levels, small studies show SubQ can be comparable with IM. People switched from IM to SubQ on the same drug kept comparable exposure, but the SubQ evidence base is smaller and shorter than the evidence for IM products.

Can testosterone cypionate be injected subcutaneously?

Published studies support SubQ use of testosterone cypionate, but current FDA labels for cypionate vials specify intramuscular use. Using one SubQ is therefore an off-label route that should be directed by the prescriber. Among the current FDA-approved injectable testosterone products reviewed for this page, Xyosted is the one labeled for SubQ use.

Is subcutaneous testosterone FDA approved?

Xyosted is an FDA-approved weekly testosterone enanthate autoinjector labeled for SubQ use in the abdomen. Standard cypionate and enanthate vials reviewed for this page are labeled for IM use. Compounded testosterone is not FDA-approved as a finished drug product and therefore has no FDA-approved route.

Does SubQ testosterone lower hematocrit?

It hasn't been proven. One 12-week study found a smaller rise with the Xyosted autoinjector than with IM cypionate vials, but it compared different products and wasn't randomized. Xyosted still raised hematocrit about 5.4 points on average over a year in its trials.

Does SubQ testosterone raise or lower estrogen?

The evidence conflicts. One study found a smaller estradiol rise with Xyosted than IM cypionate, while smaller studies found similar rises by route. Don't add estrogen-blocking drugs without your prescriber.

Is SubQ testosterone less painful?

Often in small studies, but not always. People who switched from IM to SubQ cypionate or enanthate reported less pain, while a large-volume SubQ testosterone-undecanoate injection hurt more 24 hours later in one crossover study. Product, volume and individual preference matter.

Does testosterone get stuck in belly fat?

No good evidence says so. In one study, the dose people needed didn't depend on body mass index, and imaging studies suggest many shots meant for muscle already land in fat.

Why do I get lumps after a SubQ shot?

Small lumps, bruising or redness are common SubQ site reactions and usually fade. In Xyosted's trials, 12.7% of men had a site reaction and none stopped treatment because of it. Tell your prescriber about a spot that grows, turns hot, becomes very painful or drains.

Can I switch from IM to SubQ on my own?

No. Ask your prescriber, who should set the new route and schedule, update your prescription, and tell you when to recheck your labs.

Is Xyosted better than injecting cypionate under the skin?

Xyosted is FDA-approved for SubQ use and comes as a single-use autoinjector. A current SingleCare cash-coupon listing was about $613.54 for four 100-mg pens when checked in September 2026, though price varies by strength and pharmacy. Generic cypionate is much cheaper on coupon sites, but SubQ use of an IM-labeled vial is off-label.

Does the injection route change fertility?

There is no evidence that SubQ avoids testosterone's effect on sperm production. If you're trying to conceive now or soon, discuss that goal with a urologist, reproductive urologist or another fertility-aware clinician before starting exogenous testosterone.

Is online testosterone prescribing legal in 2026?

Yes, with conditions. Testosterone is a Schedule III controlled substance and requires a valid prescription. The fourth temporary federal extension continues qualifying telemedicine prescribing flexibilities for Schedule II-V controlled medications through December 31, 2026 when the rule's conditions are met. State law can be stricter.

Does insurance cover SubQ testosterone?

It depends on the product and your plan. Xyosted may be covered, sometimes after prior authorization. Generic cypionate from your own doctor may be covered. Most online TRT programs are cash-pay, though some accept HSA or FSA funds.

---

Still not sure which TRT care route fits you? Use our free Find My TRT Path tool.

---

TRT Provider Guide is the independent decision resource for testosterone replacement therapy care. We are not a clinic, pharmacy, laboratory, drug manufacturer, insurer or medical practice. This page is educational information, not medical advice. It can't diagnose low testosterone or tell you which treatment is right for you. Testosterone is a Schedule III controlled substance in the United States and requires a valid prescription. For chest pain, trouble breathing or a painful, swollen leg, seek urgent or emergency care. Last verified September 2026.

How We Review TRT Providers · Editorial standards · Affiliate disclosure · Privacy policy · Report a correction

---